PL3305914T3 - Zastosowanie sh3yl1 jako markera do diagnozowania nefropatii - Google Patents
Zastosowanie sh3yl1 jako markera do diagnozowania nefropatiiInfo
- Publication number
- PL3305914T3 PL3305914T3 PL16803768T PL16803768T PL3305914T3 PL 3305914 T3 PL3305914 T3 PL 3305914T3 PL 16803768 T PL16803768 T PL 16803768T PL 16803768 T PL16803768 T PL 16803768T PL 3305914 T3 PL3305914 T3 PL 3305914T3
- Authority
- PL
- Poland
- Prior art keywords
- sh3yl1
- marker
- nephropathy diagnosis
- nephropathy
- diagnosis
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title 1
- 208000017169 kidney disease Diseases 0.000 title 1
- 239000003550 marker Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020150079672A KR101732706B1 (ko) | 2015-06-05 | 2015-06-05 | 신증 진단용 마커로서의 sh3yl1의 용도 |
| PCT/KR2016/005906 WO2016195415A1 (ko) | 2015-06-05 | 2016-06-03 | 신증 진단용 마커로서의 sh3yl1의 용도 |
| EP16803768.7A EP3305914B1 (en) | 2015-06-05 | 2016-06-03 | Use of sh3yl1 as marker for nephropathy diagnosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3305914T3 true PL3305914T3 (pl) | 2022-02-14 |
Family
ID=57441199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16803768T PL3305914T3 (pl) | 2015-06-05 | 2016-06-03 | Zastosowanie sh3yl1 jako markera do diagnozowania nefropatii |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP3305914B1 (pl) |
| JP (1) | JP6698154B2 (pl) |
| KR (1) | KR101732706B1 (pl) |
| ES (1) | ES2896473T3 (pl) |
| PL (1) | PL3305914T3 (pl) |
| WO (1) | WO2016195415A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115461471B (zh) * | 2020-04-30 | 2025-08-15 | 南京金斯瑞生物科技有限公司 | 一种芯片表面连接体及其制备方法和应用 |
| WO2022054029A1 (en) * | 2020-09-14 | 2022-03-17 | Celros Biotech | Sh3yl1 antibodies, compositions comprising the same, and vectors and uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5534431A (en) * | 1994-02-28 | 1996-07-09 | The Board Of Regents Of The University Of Nebraska | Hybridomas and monoclonal antibodies specific for unique determinants of nephropathy-related immunoglobulin G and complexes thereof |
| EP0915156B1 (en) * | 1996-12-05 | 2006-05-31 | Nihon University | IgA NEPHROPATHY-ASSOCIATED GENE |
| JP2003235573A (ja) * | 2002-02-13 | 2003-08-26 | Sumitomo Pharmaceut Co Ltd | 糖尿病性腎症マーカーおよびその利用 |
| GB0707735D0 (en) * | 2007-04-21 | 2007-05-30 | Imp Innovations Ltd | Methods |
| PT2391653E (pt) * | 2009-01-28 | 2015-02-13 | Ind Tech Res Inst | Biomarcadores associados a nefropatia |
| WO2011010372A1 (ja) * | 2009-07-22 | 2011-01-27 | 株式会社バイオマーカーサイエンス | 物質の評価方法及び評価用キット、物質のスクリーニング方法、並びに、糖尿病性腎症の発症の有無又は将来の発症リスクの判定方法及び判定用キット |
| JP2011141177A (ja) * | 2010-01-07 | 2011-07-21 | Juntendo | 慢性腎疾患の診断方法 |
| KR101240208B1 (ko) * | 2010-06-09 | 2013-03-06 | 고려대학교 산학협력단 | 제1형 당뇨병성 신증 진단용 단백질성 마커 |
| US20120004119A1 (en) * | 2010-06-30 | 2012-01-05 | Marc Lenburg | Gene expression markers of oncolytic virus sensitivity |
| CN102154478B (zh) * | 2010-09-21 | 2013-03-20 | 上海市精神卫生中心 | 亚综合征抑郁基因表达诊断芯片 |
| US20140155397A1 (en) * | 2011-04-01 | 2014-06-05 | Board Of Regents | Emt signatures and predictive markers and method of using the same |
| KR20110137278A (ko) * | 2011-12-12 | 2011-12-22 | 경북대학교 산학협력단 | 당뇨병성 신증 진단용 바이오마커 및 이의 동정방법 |
-
2015
- 2015-06-05 KR KR1020150079672A patent/KR101732706B1/ko active Active
-
2016
- 2016-06-03 EP EP16803768.7A patent/EP3305914B1/en active Active
- 2016-06-03 ES ES16803768T patent/ES2896473T3/es active Active
- 2016-06-03 WO PCT/KR2016/005906 patent/WO2016195415A1/ko not_active Ceased
- 2016-06-03 PL PL16803768T patent/PL3305914T3/pl unknown
- 2016-06-03 JP JP2018515748A patent/JP6698154B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20160143244A (ko) | 2016-12-14 |
| KR101732706B1 (ko) | 2017-05-04 |
| ES2896473T3 (es) | 2022-02-24 |
| WO2016195415A1 (ko) | 2016-12-08 |
| JP2018524020A (ja) | 2018-08-30 |
| EP3305914B1 (en) | 2021-10-13 |
| EP3305914A4 (en) | 2019-01-09 |
| EP3305914A1 (en) | 2018-04-11 |
| JP6698154B2 (ja) | 2020-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL247289A0 (en) | Use of 3-isoxolidinone compounds as selective herbicides | |
| ZA201705060B (en) | Use of picolinamides as fungicides | |
| HUE057057T2 (hu) | Pirazolilketon-származékok intermedierként történõ alkalmazásra | |
| ZA201700880B (en) | Polymorphs of selinexor | |
| IL252873A0 (en) | The l-tartrate salt of pridopidine | |
| PL3223837T3 (pl) | Lactobacillus do zastosowania jako probiotyk | |
| SI3154526T1 (sl) | Trdne oblike sofosbuvira | |
| IL246979A0 (en) | Crystalline forms of sofosbuvir | |
| SG11201701076TA (en) | Diagnosis of cancer | |
| GB2541587B (en) | Observation mask of dermatoscope | |
| IL240155B (en) | Marking of a fluoroscopic field of view | |
| EP3178923A4 (en) | Use of susd2 protein as marker | |
| GB201404697D0 (en) | Attachment of hoof blocks | |
| GB201608510D0 (en) | Apparatus for clinical use | |
| EP3117356A4 (en) | Diagnostic marker for treatment of cerebral ischemia | |
| PL3305914T3 (pl) | Zastosowanie sh3yl1 jako markera do diagnozowania nefropatii | |
| GB201407822D0 (en) | Use of a composition | |
| IL249130A0 (en) | Preparation of piperidine-4-carbthioamide | |
| GB201509658D0 (en) | Method of diagnosis | |
| SG11201608123VA (en) | Pharmaceutical composition for external use | |
| IL253125A0 (en) | Preparations based on tetracaine for use as an anesthetic | |
| ZA201703153B (en) | Purification of polyphenols | |
| TWI561205B (en) | Quick release structure of electrosurgical unit | |
| GB201410118D0 (en) | Early diagnosis of leptospire | |
| SG11201701589WA (en) | Improvements relating to polyurethanes |